#psilocybin

#psilocybin

Mushroom edibles often contain misleading ingredients, some of which may be illegal or harmful, posing significant health risks for consumers.

York Regional Police have dismantled an illegal psilocybin operation linked to a larger network of distribution throughout Ontario.

Magic mushrooms may have influenced the birth of human consciousness through enhanced brain connectivity and cognitive effects.

Law enforcement seizures of psilocybin have increased nearly 3.5 times from 2017 to 2022, indicating a potential increase in availability of the substance.

Psilocybin is the most consumed plant-based psychedelic, with 11.3% of people age 12 and over reporting having ever used it in 2022.

Scientists have completed the largest genomic study of magic mushrooms, analyzing the genomes of over 50 mushrooms from the Psilocybe genus.

The study found that psilocybin-making in Psilocybe evolved around 65 million years ago, and that the mushrooms evolved two independent ways of making psilocybin, one of which was previously undiscovered.

Magic mushrooms combined with cognitive behavioral therapy helped longtime smokers quit smoking with an 80% abstinence rate after six months.

Psilocybin, the active hallucinogenic agent in magic mushrooms, can lead to deep reflection and motivation to change when administered in a therapeutic context.

Psilocybin in magic mushrooms has a long-lasting effect on the brain, influencing space, time perception, self, and aiding in depression treatment.

Microdosing psilocybin helped Peggy Van de Plassche alleviate longstanding depression and anxiety that persisted despite her successes in the finance industry.

Psilocybin may effectively treat body dysmorphic disorder (BDD), showing promise in enhancing brain connectivity related to emotional and executive function.

The call for psilocybin research highlights its potential benefits for mental health treatment and the need for changes in drug scheduling regulations.

Psilocybin induces significant changes in brain networks, including a loss of self-identity, surpassing effects of methylphenidate.

Psilocybin from psychedelic mushrooms shows promise in treating mental health issues like depression.

Psilocybin induces altered states of consciousness, enhancing sensitivity to the environment, visual disturbances, and mystical experiences in a span of 4-6 hours.

Research indicates psilocybin alters brain networks related to introspective thinking, shedding light on the neurobiological basis of psychedelic experiences.

The study of brain changes during psychedelic trances opens doors for therapeutic applications against psychiatric disorders like resistant depression and addictions.

Psychedelic drugs like psilocybin disrupt brain networks, altering space, time, and self-perception, leading to enhanced plasticity and potential therapeutic benefits for addiction or depression.

Blocking inflammation-boosting protein IL-11 in mice leads to longer, healthier lives.

Magic mushrooms reset brain networks affecting time and self.

Psilocybin-induced changes in the brain's networks can provide valuable insights for further understanding its therapeutic potential.

Psilocybin triggers widespread brain changes lasting weeks,

Researchers at Washington University School of Medicine studied brain scans of participants on psilocybin, showing significant departure from normal activity patterns, offering insights for mental health disorders.